These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5718186)

  • 1. [pH, titrable acidity and urinary buffer power in oxalic lithiasis, gout and uric lithiasis].
    Thomas J; Thomas E; Rabussier H; Desgrez P
    J Urol Nephrol (Paris); 1968 Sep; 74(9):690-3. PubMed ID: 5718186
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of pH, of titrable acidity, and urinary buffer system in oxalate lithiasis, in gout and urate lithiasis].
    Thomas J; Thomas E; Rabussier H; Desgrez P
    Rein Foie; 1968; 11():109-70. PubMed ID: 5741315
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent data on the urinary excretion of oxalic acid in oxalic renal lithiasis].
    Thomas J; Melon JM; Thomas E; Steg A; Desgrez P; Aboulker P
    Ann Urol (Paris); 1972 Feb; 6(1):31-3. PubMed ID: 5012700
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation of renal stones may be prevented by restoring normal urinary composition.
    Pak CY
    Proc Eur Dial Transplant Assoc; 1983; 20():371-85. PubMed ID: 6361751
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary hydrogen ion concentration as one of the pathogenetic factors of urinary calculi].
    Edinyĭ IuG; Dziurak VS; Zheltovskaia NI; Chernenko VV; Sveshnikov AV
    Vrach Delo; 1987 Dec; (12):57-9. PubMed ID: 3445570
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oxalic lithiasis and disorder of uric acid metabolism].
    Mugler A
    J Urol Nephrol (Paris); 1970 Dec; 76(12):423-34. PubMed ID: 5522994
    [No Abstract]   [Full Text] [Related]  

  • 7. [Personal experiences in the long-term treatment of cystine lithiasis with high-dose ascorbic acid].
    Brundig P; Börner R; Berg W
    Z Urol Nephrol; 1982 Nov; 75(11):759-70. PubMed ID: 7164603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis.
    Takasaki E; Shimano E
    Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G; Haton D; Wolf JP; Henriet MT; Nguyen NU; Mougin C; Saint-Hillier Y; Combes M; Berthelay S
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of dietary factors on renal lithiasis].
    Jaeger P
    Ther Umsch; 1986 Oct; 43(10):779-84. PubMed ID: 3824255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Staining of uric acid crystals with methylene blue].
    Kleeberg J
    Z Urol Nephrol; 1972 Aug; 65(8):619-29. PubMed ID: 4119477
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of urinary calculi by chemical methods.
    Naqvi SA; Rizvi SA; Shahjehan S
    J Pak Med Assoc; 1984 Jun; 34(6):147-53. PubMed ID: 6433055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and chemical factors in kidney calculus formation in childhood. An analysis of 40 patients].
    Böhles H; Brandl U; Schott G; Stehr K
    Monatsschr Kinderheilkd; 1984 Mar; 132(3):158-62. PubMed ID: 6727888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endogenous oxalic acid and its role in oxalosis and oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1982 Aug; 75(8):617-24. PubMed ID: 7180224
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxalic acid excretion in oxalate lithiasis.
    McINTOSH JF; READ MK
    J Urol; 1958 Oct; 80(4):272-4. PubMed ID: 13576609
    [No Abstract]   [Full Text] [Related]  

  • 16. Ascorbic acid is an abettor in calcium urolithiasis: an experimental study.
    Singh PP; Kiran R; Pendse AK; Gosh R; Surana SS
    Scanning Microsc; 1993 Sep; 7(3):1041-7; discussion 1047-8. PubMed ID: 8146605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ribomononucleotides given orally on uric acid production in man.
    Gutman AB; Yü TF
    Adv Exp Med Biol; 1974; 41():401-5. PubMed ID: 4832563
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive treatment of oxalic lithiasis with an hypo-oxaluric: agent succinimide].
    Thomas J; Melon JM; Steg A; Aboulker P
    J Urol Nephrol (Paris); 1971 Dec; 77():Suppl:534-40. PubMed ID: 5155480
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitor of calcium-oxalate crystal growth in primary bladder-stone disease.
    Teotia M; Teotia SP
    Lancet; 1972 Mar; 1(7750):599. PubMed ID: 4110087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.